Literature DB >> 17559095

Post-pubertal emergence of alterations in locomotor activity in stop null mice.

Mélina Bégou1, Philippe Brun, Jean-Baptiste Bertrand, Didier Job, Annie Schweitzer, Thierry D'Amato, Mohamed Saoud, Annie Andrieux, Marie-Françoise Suaud-Chagny.   

Abstract

Overt schizophrenia is preceded by a prodromal phase during which juvenile patients display attenuated schizophrenia-related symptoms. Here, we have looked for evidence of a prodromal phase in juvenile STOP null mice, which, during adulthood, imitate features of schizophrenia. We have principally examined locomotor activity, which is abnormal in adult STOP null mice, and its apparent relationship with perturbed glutamatergic and dopaminergic transmission. When compared to corresponding wild-type mice, juvenile STOP null mice did not exhibit the basal hyperlocomotion or locomotor hypersensitivity to mild stress observed in adult mice. Juvenile STOP null mice also lacked disturbed locomotor sensitivity to MK-801, which was evident in adult mice. In contrast, juvenile STOP null mice exhibited a similar hypersensitivity to amphetamine as that found in adult mice. Thus, STOP null mice exhibited both a progression of locomotor activity defects over time and subtle alterations in the prepubertal period. We suggest that the pattern of locomotor disturbances observed in this study is related to altered dopaminergic reactivity in juvenile mice without major disturbance in glutamatergic transmission, whereas both neurotransmitter systems are impaired in adult mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559095     DOI: 10.1002/syn.20409

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  5 in total

1.  Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice.

Authors:  David Delotterie; Geoffrey Ruiz; Jacques Brocard; Annie Schweitzer; Corinne Roucard; Yann Roche; Marie-Françoise Suaud-Chagny; Karine Bressand; Annie Andrieux
Journal:  Psychopharmacology (Berl)       Date:  2009-11-21       Impact factor: 4.530

2.  Altered circadian activity and sleep/wake rhythms in the stable tubule only polypeptide (STOP) null mouse model of schizophrenia.

Authors:  Samuel Deurveilher; Kristin Robin Ko; Brock St C Saumure; George S Robertson; Benjamin Rusak; Kazue Semba
Journal:  Sleep       Date:  2021-04-09       Impact factor: 5.849

3.  Loss of STOP protein impairs peripheral olfactory neurogenesis.

Authors:  Karelle Benardais; Basem Kasem; Alice Couegnas; Brigitte Samama; Sebastien Fernandez; Christiane Schaeffer; Maria-Cristina Antal; Didier Job; Annie Schweitzer; Annie Andrieux; Anne Giersch; Astrid Nehlig; Nelly Boehm
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

4.  Deletion of the microtubule-associated protein 6 (MAP6) results in skeletal muscle dysfunction.

Authors:  Muriel Sébastien; Benoit Giannesini; Perrine Aubin; Julie Brocard; Mathilde Chivet; Laura Pietrangelo; Simona Boncompagni; Christophe Bosc; Jacques Brocard; John Rendu; Sylvie Gory-Fauré; Annie Andrieux; Anne Fourest-Lieuvin; Julien Fauré; Isabelle Marty
Journal:  Skelet Muscle       Date:  2018-09-19       Impact factor: 4.912

5.  Reduced expression of STOP/MAP6 in mice leads to cognitive deficits.

Authors:  Julien Volle; Jacques Brocard; Mohamed Saoud; Sylvie Gory-Faure; Jérôme Brunelin; Annie Andrieux; Marie-Françoise Suaud-Chagny
Journal:  Schizophr Bull       Date:  2012-09-20       Impact factor: 9.306

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.